Trending Topic

2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

From advances in targeted therapies to the integration of AI and steps towards precision medicine, 2024 brought many exciting developments in the field. With 2025 now unfolding, many of these are likely to continue gaining momentum and potentially redefine patient care. In this latest edition of touchREVIEWS in RMD, we’re excited to present a collection […]

Pia Kvistborg, ESMO 2020 – The ORF1ab of SARS-CoV-2 Encodes an Immunodominant Epitope Restricted by HLA-A*01:01

Pia Kvistborg
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 21st 2020

touchIMMUNOLOGY meets Dr Pia Kvistborg at the Virtual 2020 ESMO Congress to discuss the presentation of her late-breaking abstract ‘The ORF1ab of SARS-CoV-2 encodes an immunodominant epitope restricted by HLA-A*01:01’ (LBA73) and initial findings from her recent study.

Questions

  1. How did your collaboration with Andrea Cossarizza on SARS-CoV-2 come about? (0:12)
  2. How have you applied cancer research technology to elucidate structural components of the SARS-CoV-2 virus? (1:04)
  3. Could you give us an overview of the aims and design of your recent study? (2:40)
  4. What were the main findings of your study? (4:48)
  5. What are the implications of these findings on vaccine design? (10:55)

Speaker Disclosure: Pia Kvistborg has nothing to disclose in relation to this interview.

Support: Interview and filming supported by Touch Medical Media Ltd.

Filmed in coverage of the Virtual 2020 ESMO Congress.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup